Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 06.10.2026 FEUZ IE00B8X9NY41 1,682,584.00 EUR 107,152,114.13   63.683  ...
-

Forsee Power : Informations relatives au nombre de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers (AMF)

PARIS--(BUSINESS WIRE)--Regulatory News: Forsee Power (Paris:ALFOR) : Date Nombre d’actions composant le capital social Nombre de droits de vote BRUT (1) Nombre de droits de vote NET (2) 30/09/2026 117 472 439 129 544 916 129 019 449 (1) Conformément à l’article 223-11 du Règlement général de l’Autorité des marchés financiers, nombre calculé sur la base de l’ensemble des actions auxquelles sont attachées des droits de vote, y compris les actions privées de droit de vote (auto-détention, contrat...
-

LE SLIP FRANÇAIS : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL

PARIS--(BUSINESS WIRE)--Regulatory News: Le Slip Français (Paris:ALLSF): Date d’arrêté : 30 septembre 2026   Nombre total d’actions composant le capital social   1 299 152   Nombre de droits de vote théoriques (1)     1 624 994     Nombre total de droits de vote exerçables (2)   1 624 092 (1) Le nombre de droits de vote théoriques (ou droits de vote « bruts ») sert de base au calcul pour les franchissements de seuils. Conformément à l’article 223-11 du Règlement Général de l’AMF, ce nombre est...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 06.10.2026 FEM IE00B8X9NX34  300,002.00 USD  15,748,169.10   52.494  ...
-

NASRC Opens Registration for 2026–27 Natural Refrigerant Training Events

MILL VALLEY, Calif.--(BUSINESS WIRE)--The North American Sustainable Refrigeration Council (NASRC), a 501(c)(3) nonprofit working to facilitate the transition to natural refrigerants, has opened registration for five Natural Refrigerant Training Events through R-TRADE, NASRC’s nationwide workforce development initiative. The free events will provide practical, expert-led training for refrigeration technicians at every level of experience with CO2 and propane technologies. Programming includes c...
-

USA Volleyball Names Heidi Taliaferro as General Counsel

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--USA Volleyball names former Stanford NCAA champion and S&P 500 legal exec Heidi Taliaferro as General Counsel ahead of the 2027 World Cup & LA28....
-

A⁵ Media Group Launches Global Content, Commerce and Technology Company to Enable Brands, Entertainment and Sports Entities to Turn Direct Audience Relationships Into Revenue

NEW YORK--(BUSINESS WIRE)--A⁵ Media Group launched today to help brands, entertainment and sports entities regain control of their valuable direct audience relationships....
-

Chef Robotics Advances Physical AI for Food Manipulation With the NVIDIA Isaac Platform

SAN FRANCISCO--(BUSINESS WIRE)--Chef Robotics, the first company to commercialize a scalable physical AI food robotics solution, today announced it is building on NVIDIA's robotics development stack — including NVIDIA Isaac Sim, built on NVIDIA Omniverse libraries, and NVIDIA cuMotion — to accelerate the development and deployment of its food-manipulation robotic systems. Food is one of the most demanding manipulation environments in the physical world. Ingredients are deformable, wet, and high...
-

Oncodesign Precision Medicine franchit plusieurs jalons scientifiques et réglementaires majeurs dans le cadre du programme LARKIN, soutenu par la Fondation Michael J. Fox (MJFF)

DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision, annonce aujourd’hui plusieurs avancées stratégiques dans le développement d’OPM-201, son inhibiteur de la kinase LRRK2 destiné au traitement de la maladie de Parkinson. Ces avancées surviennent six mois après le lancement du programme LARKIN, soutenu par une subvention du Therapeutic Pipeline Program (...
-

OPM Achieved Several Major Scientific and Regulatory Milestones as Part of the LARKIN Program, Supported With Funding By The Michael J. Fox Foundation for Parkinson's Research (MJFF)

DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Ticker symbol: ALOPM), a biopharmaceutical company specializing in precision medicine, today announced several strategic advances in the development of OPM-201, its LRRK2 kinase inhibitor for the treatment of Parkinson’s disease. These advances come six months after the launch of the LARKIN program, supported by a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) thro...